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Objective: To determine the validity of the Asthma Control Test (ACT) questionnaire for asses-
sing pregnant asthmatic women.
Methods: The study involved 40 pregnant asthmatic women over a total of 113 medical visits.
On each occasion the participants had a pulmonary function test and a clinical evaluation to
assess the level of asthma control. In addition, the ACT was carried out with the obstetrician
being blinded to its results.
Results: The most accurate cut-off point was 16, with a sensitivity of 95.4%, specificity of
68.8%, a negative predictive value of 91.7% and a positive predictive value of 80.5%. The pos-
itive and negative likelihood ratios were 3.052 and 0.067 respectively. The questionnaire was
found to be highly effective for discriminating between controlled and uncontrolled asthma,
with an area under the receiver operating characteristic (ROC) curve of 0.846 (95%CI: 0.748
e0.92). Reliability assessed in patients with the same clinical classification resulted in an
intra-class correlation coefficient of 0.86 (95%CI: 0.75e0.93). Improved clinical conditions cor-
responded to a significant increase in the ACT score (p < 0.005), indicating good responsiveness
to changes in clinical status.oata˜o 161/apt 302, Torre, Recife, Pernambuco, Brazil. CEP 50710030. Tel.: þ81 87429481, þ81
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1590 M. Monteiro de Aguiar et al.Conclusions: The ACT proved to be reliable and could discriminate between levels of asthma
control in pregnant women confirming its value as a useful tool for the management of asthma
during pregnancy.
ª 2014 Elsevier Ltd. All rights reserved.Introduction
Asthma is characterized by an increase in airway sensitivity
and chronic inflammation leading to an obstruction that is
partially or completely reversible [1]. It is the most common
chronic disease in women of reproductive age [2], affecting
up to 8% of pregnant women in the United States [3].
The course of asthma in pregnantwoman is unpredictable.
Improvement is observed in one-third of cases, deterioration
in another third and no change in the remainder [4]. Pregnant
asthmatic women are at an increased risk of experiencing
preeclampsia, premature delivery, intrauterine growth re-
striction, and of being submitted for cesarean section [1,5].
Furthermore, asthmatic exacerbations during pregnancy are
associatedwith an increased risk of congenitalmalformations
[6]. However, when well-controlled, asthma is associated
with a good fetal and maternal prognosis [7]. Therefore,
keeping the disease under control is pivotal for an uneventful
pregnancy and a healthy newborn infant [8].
A subjective evaluation of asthma control can be of no
assistance in distinguishing between well-controlled and
uncontrolled patients, leading either to insufficient treat-
ment or to excessive medication [9,10]. In pregnant
women, shortness of breath is the most common respiratory
complaint. However, this physiological dyspnea is not
associated with the other typical symptoms of asthma such
as wheezing, coughing and chest tightness [11,12]. Thus
obstetricians unfamiliar with the disease may find it diffi-
cult to evaluate the level of asthma control in pregnant
women due to the numerous peculiarities and complaints
produced by pregnancy itself.
The ACT questionnaire was developed in 2004 by Nathan
et al. [13] and can be self-administered. It can be used for
identifying patients with poorly controlled asthma and for
monitoring treatment [14]. It has been validated in Spain
[15], China [16], Korea [17], North Africa [18], Brazil [19],
Greece [20], Vietnam [21] and Turkey [22]. Some authors
have recommended its use to evaluate pregnant women [23].
However, to the best of our knowledge, no studies have
assessed ACT’s performance in pregnant asthmatic women
and it is not known to what extent the presence of the
breathlessness due to pregnancy itself may alter the value
of the ACT score. Thus the objective of the present study
was to assess the ability of the ACT questionnaire to
distinguish between pregnant women with controlled
asthma from those with poorly controlled disease and verify
its reliability and responsiveness.
Patients and methods
A convenience sample of forty pregnant women was
recruited from consecutive patients seeking care at thesub-specialty outpatient department for asthma in preg-
nancy located at the Hospital das Clı´nicas, the teaching
hospital at the Federal University of Pernambuco (UFPE),
Brazil, between December 2011 and October 2012. The
women were 18 years of age or more, of more than 12
weeks in gestational age and had had a positive diagnosis
for asthma. The study was approved by the institutional
ethics committee and all patients signed an informed con-
sent form.
A validation study was chosen as the most appropriate
study design. Evaluations were conducted prior to delivery
over a maximum of four visits scheduled at least four weeks
apart. At each visit, the patients answered the Portuguese
version of the ACT questionnaire [19], while a single
obstetrician trained in the management of pregnant women
with asthma performed a clinical evaluation and spirom-
etry. Asthma diagnosis was confirmed by the clinical history
and a previous increase of more than 12% in the one-second
forced expiratory volume (FEV1) after bronchodilation [24].
The first procedure at each visit was the pulmonary
function test conducted using spirometry. The variable
FEV1, expressed as a percentage of the predicted value,
was the parameter used to evaluate the degree of airway
obstruction. Next, the ACT questionnaire was completed.
Since there was no restriction in the study protocol on the
inclusion of individuals with little or no schooling, the
questionnaire was applied by interviewers, who had been
instructed not to interpret the questions or influence the
patients’ answers. The pregnant women were asked to
refer to their experiences with asthma during the previous
four weeks and to answer the questions on the form.
At the end of each visit there was a clinical evaluation in
accordance with the Global Initiative for Asthma (GINA)
guidelines [24], which, in association with the pulmonary
function test results, is considered the gold standard for
asthma control. The obstetrician conducting these evalua-
tions had specific training in asthma diagnosis during
pregnancy and was blinded to the results of the ACT. At the
first visit, clinical examination confirmed the diagnosis of
asthma, evaluated its severity and classified the control
level of the disease in accordance with the criteria pro-
posed in the GINA guidelines [24]. At the following visits,
the procedures consisted of evaluating the level of asthma
control during the preceding four weeks.
Based on the GINA criteria, the patients were divided
into controlled and uncontrolled asthma groups e the latter
including partially controlled and uncontrolled cases. To
evaluate the capacity of the ACT to distinguish between
controlled and uncontrolled asthma, the patients were
classified based on a score that ranged from 5 to 25. Vali-
dation measures were applied for each of the scores -
sensitivity, specificity, positive and negative predictive
Table 1 Characteristics of the pregnant women enrolled
to the study.
Characteristic Number of women
Number of participants at:
First visit 40
Second visit 33
Third visit 27
Fourth visit 13
Median age (Range) in years 24 (18e44)
Family income in US dollar
(median e P25; P75)
387 (264; 575)
Years of schooling
1e8 14 (35.0%)
9e11 23 (57.5%)
12 03 (7.5%)
Classification of severity
Intermittent 11 (27.5%)
Mild persistent 06 (15.0%)
Moderate persistent 12 (30.0%)
Severe persistent 11 (27.5%)
FEV1 (First visit/total)
<60% 7 (17.5%)/12 (10.6%)
60e79% 18 (45%)/34 (30%)
>80% 15 (37.5%)/67 (59.3%)
Comorbidities
Smoking 03 (7.5%)
Allergy 30 (75.0%)
Rhinitis 19 (47.5%)
Previous diagnosis of asthma 37 (92.5%)
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test.
Accuracy was determined from the area under the
receiver operating characteristic (ROC) curve and used to
calculate the proportion of patients who had been correctly
classified by the questionnaire. The intra-class correlation
coefficient was used to assess reliability for patients
maintaining the same level of control over more than one
visit. The Wilcoxon test was used to evaluate responsive-
ness according to variations in the ACT scores of the pa-
tients whose clinical status changed between two
evaluations. The statistical analyses were conducted using
the Stata software program, version 12.1SE and the EpiInfo
program, version 3.04.
Results
The initial study sample consisted of 40 pregnant women.
There was a cumulative loss-to-follow-up during subse-
quent visits and asthma control assessment was based on
113 evaluations. The median age of the women was 24
years (range 18e44 years), median family income was 387
dollars, and slightly more than half the participants (57.5%;
nZ 23) had between 9 and 11 years of schooling. FEV1 was
>80% of the predicted value in 67 evaluations (59.3%).
Three of the forty women (7.5%) reported smoking. Allergy
was reported by 30 women (75%) and rhinitis by 19 (47.5%),
while 37 of the 40 participants (92.5%) reported having a
previous diagnosis of asthma. In accordance with the
asthma severity classification, 27.5% of the women in the
study had intermittent asthma, while 15% had mild persis-
tent, 30% moderate persistent and 27.5% severe persistent
asthma (Table 1).
Table 2 shows the values for sensitivity, specificity,
positive and negative predictive values and likelihood ratios
for the various ACT scores. The highest accuracy of the ACT
score distinguishing controlled from uncontrolled asthma
was found with a cut-off value of 16 points (84%), with high
sensitivity (95.4%) and high negative (91.7%) and positive
predictive (80.5%) values. Specificity was 68.8%, the posi-
tive likelihood ratio was 3.05 and the negative likelihood
ratio was 0.067. The area under the ROC curve was 0.846
(95% CI: 0.748e0.920) (Fig. 1).
The intra-class correlation coefficient was 0.86 (95% CI:
0.75e0.93). This variable provides a measurement for the
level of control of the patients who remained stable be-
tween two or more clinical evaluations. In order to evaluate
responsiveness the questionnaires of 10 patients whose
clinical condition improved from poorly controlled to
controlled between one clinical evaluation and another
were assessed. The median ACT score was 11 points (range
9e14) in patients with poorly controlled asthma and 20.5
points (range 18e24) in those whose clinical classification
improved (p < 0.005) indicating that the questionnaire can
detect clinical change (Fig. 2).
Discussion
To the best of our knowledge, this is the first study to
evaluate prospectively the ACT reliability in identifying
uncontrolled asthma and its responsiveness to treatment inpregnant women. The results show that a test score of 16
resulted in the highest accuracy for distinguishing
controlled from uncontrolled disease. The sensitivity, pre-
dictive positive and negative values and likelihood ratios
were similar to those found by others in non-pregnant pa-
tients [13e22].
However, the specificity of the ACT was slightly lower
(68.8%) but also comparable with that found in non-
pregnant patients (70.8e78.5%) [13e22]. This finding
could be also a consequence of the pregnancy on
symptoms perception by the patients and should call
some caution to its applicability as a diagnostic confir-
mation test of adequate control of the disease. How-
ever, the ACT questionnaire should still be used as a
screening tool because in an un-specialized office it is
more important to identify patients that need of asthma
care. In this situation the benefits of high sensitivity
more than offset the slight loss in specificity.
Although our findings indicate that a cut-off point of 16
provides the best accuracy for distinguishing controlled
from uncontrolled asthma, when our results are compared
to those of Schatz et al. [14], we can conclude that a cut-
off point of 19 also shows a good balance between sensi-
tivity (86%) and specificity (75%) for detecting patients with
partially controlled disease (Table 2) and should call
attention as an indication of asthma control problems.
The good responsiveness found shows that the ACT was
able to identify changes in asthma control in patients who
Table 2 Characteristics of the ACT questionnaire applied to the pregnant women.
Cut-off point
(ACT score)
Sensitivity (%) Specificity (%) Accuracy (%) Likelihood ratio PPV (%) NPV (%)
Positive Negative
7 100 0 57.5 1 . 57.5 100
8 100 4.2 59.3 1.043 0 58.6 100
9 100 12.5 62.8 1.143 0 60.7 100
10 100 18.8 65.5 1.231 0 62.5 100
11 100 27.1 69.0 1.371 0 65.0 100
12 100 33.3 71.7 1.500 0 67.0 100
13 100 41.7 75.2 1.714 0 69.9 100
14 98.5 47.9 77.0 1.890 0.032 71.9 95.8
15 98.5 60.4 82.3 2.487 0.025 77.1 96.7
16 95.4 68.8 84.1 3.052 0.067 80.5 91.7
17 92.3 70.8 83.2 3.165 0.109 81.1 87.2
18 90.8 70.8 82.3 3.165 0.109 80.8 85
19 86.2 75.0 81.4 3.446 0.185 82.4 80
20 76.9 77.1 77.0 3.357 0.299 82.0 71.2
21 67.7 87.5 76.1 5.415 0.369 88.0 66.7
22 61.5 87.5 72.6 5.415 0.369 87.0 62.7
23 52.3 87.5 67.3 5.415 0.369 85.0 57.5
24 30.8 93.8 57.5 4.923 0.738 87.0 50
25 10.8 97.9 47.8 5.169 0.911 87.5 44.8
PPV: positive predictive value; NPV: negative predictive value.
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result is similar to those found with the Portuguese, Turkish
and Spanish versions [19,22,15].
The reliability of the ACT questionnaire was high, with
an intra-class correlation coefficient of 0.86, a value that is
higher than that reported for the original version of the test
[13].
Although the ACT was constructed as a self-answered
questionnaire, in the present study it was applied byFigure 1 ROC curve for the ability of the ACT to identify
patients with uncontrolled asthma. Area under the
curve Z 0.846 (95% CI: 0.748e0.920).interviewers in order to homogenize procedures and avoid
bias. Although this could be seen as a caveat for its general
acceptability, the training of the health allied professionals
that obtained the answers posed no difficulties and
completion of questionnaire answering was in less than
5 min.
In a busy primary obstetric practice, the answers to the
questionnaire can be obtained by an easily trained health
allied professional, especially for patients with little
schooling or language difficulties, saving time for the
physician and offering a rapid evaluation of asthma control
status, allowing better decisions for therapeutics changes
and follow-up of disease control.
Together these results show that the ACT is a simple but
accurate tool for evaluating asthma control in pregnancyFigure 2 Responsiveness of the ACT questionnaire to
improvement in symptoms in treated patients evaluated at two
separate visits (p < 0.005).
Asthma Control Test validity in pregnancy 1593with the ability to identify those women in need of
specialist intervention.
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